Journal or Publishing Institution: Reproductive Toxicology
Date of Publication: 12/01/2011
Study: http://www.sciencedirect.com/science/article/pii/S0890623811003844
Author(s): Aziz, A.
Article Type: Journal Publication
Abstract:
We thank Dr. Breum and his colleagues for their interest in our study. As representatives of Bayer CropScience (BCS), the primary registrant of the active ingredient glufosinate-ammonium, they expressed some questions about our results showing the presence of glufosinate and its metabolite 3-MPPA in the serum of pregnant and non-pregnant women.
We discuss the following issues: (1) 3-MPPA vs. NAG; (2) Toxicological effects of 3-MPPA vs. glufosinate; (3) 3-MPPA analysis; (4) Absorption, distribution, metabolism and elimination (ADME) of glufosinate and 3-MPPA; (5) Factors influencing the detection of glufosinate and 3-MPPA in pregnant women; (6) Conclusions.
Keywords: Bayer CropScience, glufosinate, 3-MPPA, pregnancy, reproductive health, reproductive toxicity, pesticides, herbicides, human health, health risks, biosafety
Citation:
Aziz, A., 2011. Response to Bayer CropScience’s position on the findings of glufosinate and its metabolite. Reproductive Toxicology, 32(4), pp. 496-497.
Category:
- Health effects
- Pesticide use
Record ID: 75
